ArticleCase reports in oncology
Dermatofibrosarcoma Protuberans of the Breast: A Rare Case Report.
Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Dermatofibrosarcoma protuberans (DFSP) is a rare soft tissue sarcoma that grows from the dermis and is most commonly found in the trunk and proximal extremities. It is characterized by frequent local recurrences and invasive growth. Despite its rarity, DFSP can occur in the breast. In this report, we describe the successful treatment of a rare case of DFSP of the breast that resulted in long-term disease-free survival. Case Presentation: A 43-year-old Syrian woman diagnosed with a right breast mass and underwent a lumpectomy, which revealed DFSP. Subsequent imaging studies and biopsies excluded metastatic disease. Over the following years, the patient developed several benign breast, axillary, uterine, and flank lesions. At 6-year follow-up, she had no signs of local recurrence or metastasis. Conclusion: This case report highlights the importance of early diagnosis and appropriate management of DFSP, even in unusual locations such as the breast. Overall, 6 years follow-up remains essential to monitor for any recurrences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.